Table 3.
Multivariable analysis and risk scoring system for ritodrine-induced adverse events.
| Parameters | Crude Odds Ratio | Adjusted Odds Ratio | Score |
|---|---|---|---|
| Age ≥ 35 years | 1.43 (0.59–3.49) | 1.90 (0.69–5.27) | |
| Gestational age < 30 weeks | 1.41 (0.71–2.80) | 1.66 (0.79–3.49) | |
| Height < 160 cm | 2.54 (1.25–5.17) * | 2.41 (1.13–5.12) * | 0, 1 a |
| GNAS rs7121 | 0.60 (0.36–0.99) * | 1.00 (0.51–1.97) | |
| GNAS rs3730168 | 2.18 (1.26–3.79) ** | 2.10 (1.03–4.30) * | 0, 1, 2 b |
| RGS2 rs1152746 | 2.39 (1.05–5.41) * | 2.63 (1.07–6.49) * | 0, 1, 2 b |
Logistic regression analysis was carried out with variables of age, gestational age, height, GNAS rs7121, GNAS rs3730168, and RGS2 rs1152746. * p-value < 0.05, ** p-value < 0.01. a Height < 160 cm was assigned to score 1 (0: ≥160 cm; 1: <160 cm). b Number of the variant allele was assigned to each score (0: GG, 1: GA, 2: AA for rs3730168; 0: CC, 1: CT, 2: TT for rs1152746).